Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

US Patent 11981731 · Granted May 14, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TCR antibody molecules and uses thereof2025
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Multispecific antibody molecules comprising lambda and kappa light chains2025
Switch costimulatory receptors2025
Chimeric antigen receptors and uses thereof2025
Antibody molecules that bind to NKP30 and uses thereof2025
Multifunctional molecules that bind to T cell related cancer cells and uses ther2025
Compositions and methods for generating a persisting population of T cells usefu2025
Anti-TCR antibody molecules and uses thereof2025
CD19 and CD22 chimeric antigen receptors and uses thereof2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025